Acurx Pharmaceuticals, Inc. (ACXP) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$2.01
-0.99%
Mkt Cap $3.10M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 13, 2026 | — | — | — | -$1.01 | -$0.31 | +69.31% | — | — |
| Q4 2025 Nov 12, 2025 | — | — | — | -$1.61 | -$1.23 | +23.60% | — | — |
| Q3 2025 Aug 11, 2025 | — | — | — | -$2.00 | -$1.89 | +5.50% | — | — |
| Q2 2025 May 12, 2025 | — | — | — | -$0.15 | -$2.20 | -1366.67% | — | — |
| Q1 2025 Mar 17, 2025 | — | — | — | -$0.18 | -$0.16 | +11.11% | — | — |
| Q4 2024 Nov 12, 2024 | — | — | — | -$0.23 | -$0.17 | +26.09% | — | — |
| Q3 2024 Aug 9, 2024 | — | — | — | -$0.28 | -$0.26 | +7.14% | — | — |
| Q2 2024 May 14, 2024 | — | — | — | -$0.24 | -$0.28 | -16.67% | — | — |
| Q1 2024 Mar 15, 2024 | — | — | — | -$0.26 | -$0.38 | -46.15% | — | — |
| Q4 2023 Nov 13, 2023 | — | — | — | -$0.28 | -$0.24 | +14.29% | — | — |
| Q3 2023 Aug 14, 2023 | — | — | — | -$0.29 | -$0.28 | +3.45% | — | — |
| Q2 2023 May 12, 2023 | — | — | — | -$0.34 | -$0.25 | +26.47% | — | — |
| Q1 2023 Mar 16, 2023 | — | — | — | -$0.25 | -$0.28 | -12.00% | — | — |
| Q4 2022 Nov 14, 2022 | — | — | — | -$0.28 | -$0.32 | -14.29% | — | — |
| Q3 2022 Aug 15, 2022 | — | — | — | -$0.35 | -$0.26 | +25.71% | — | — |
| Q2 2022 May 11, 2022 | — | — | — | -$0.33 | -$0.26 | +21.21% | — | — |
| Q1 2022 Mar 17, 2022 | — | — | — | -$0.40 | -$0.23 | +42.50% | — | — |
| Q4 2021 Nov 12, 2021 | — | — | — | — | -$0.46 | — | — | — |
| Q3 2021 Aug 16, 2021 | — | — | — | — | -$0.57 | — | — | — |
| Q2 2021 Jun 28, 2021 | — | — | — | — | -$0.11 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$0.15 | — | — | — |
| Q3 2020 Sep 30, 2020 | — | — | — | — | -$0.14 | — | — | — |
| Q2 2020 Jun 30, 2020 | — | — | — | — | -$0.10 | — | — | — |
| Q1 2020 Mar 31, 2020 | — | — | — | — | -$0.13 | — | — | — |